Lyra Therapeutics

LYRA

NASDAQHealth Care

Income Statement

Total Revenue$1.53M

Gross Profit$1.53M

Operating Income$-96.35M

EBITDA$-92.93M

EBIT$-93.4M

Pre-tax Income$-32.93M

Net Income$-93.44M

Cash Equivalent$30.01M

Total Debt$36.08M

Book Value$35.17M

Book Value Per Share27.96

Return on Equity (ROE)-805.89%

Return on Assets (ROA)-140.83%

Return on Invested Capital (ROI)-805.89%

Net Profit Margin-6090.94%

Current Ratio3.41

Quick Ratio3.21

Long-Term Debt / Equitynull